Prolgolimab

Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma.
Read more
€0.00 (tax incl.)
Reference:
HY-P99807
Product Details
HY-P99807

Data sheet

Size
Multiple sizes
Reactivity
PD-1/PD-L1
Application
Cancer-programmed cell death
CAS
2093956-19-3

Menu

Settings